About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sublingual Immunotherapy In Alternaria-Induced Rhinitis

NCT01127035·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Genova

Age

14–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Allergic rhinitis
Symptoms May-October
Specific IgE to alternaria (skin test/radioallergosorbent \[RAST\] test)
Age \>14

You may not be if

Sensitization to mites, parietaria, mugwort
Pregnancy-lactation
Malignancies
Chronic systemic steroids
Previous immunotherapy to alternaria

The record

StatusCompleted

PhasePhase 4

Taking part27

StartedJan 2006

UpdatedJun 7, 2010

Conditions

Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata

Where1

Rimini Hospital
Rimini, Italy

Clareo Health | Sublingual Immunotherapy In Alternaria-Induced Rhinitis